Table 1. S19-GFP vaccination protocols of 25 crossbred heifers of 8–11 months of age.
Group | Vaccination route | N° of animals | Dosesa | GST-GFP boostb | Week of boost |
---|---|---|---|---|---|
A | Subcutaneousc | 5 | S19-GFP | None | None |
B | Subcutaneous | 10 | S19-GFP + GFPd | 150 μg | 7 |
C | Subcutaneous | 5 | S19-GFP | 150 μg | 7 |
D | Conjunctivale | 5 | S19-GFP | 150 μg | 7 |
aIndividual S19-GFP vaccine suspensions contained 5×109 CFU.
bIndividual GST-GFP boosting doses were always diluted in 2 mL of a 1% sterile calcium alginate suspension and administered subcutaneously.
cSubcutaneous vaccine was prepared in 2 mL of 0.1M sterile PBS.
dWhen required the 300 μg of GFP given simultaneously with the S19-GFP was directly dissolved in the corresponding vaccine suspension.
eConjunctival vaccine was prepared in 70 μL of 0.1M sterile PBS.